otros
US FDA approves Lilly's Mounjaro to reduce cardiovascular risk
US FDA approves Lilly's Mounjaro to reduce cardiovascular risk
Reuters · 2026-08-28 12:01
📱 Ver más noticias en Prensly
Leer la nota original ↗
Noticias relacionadas
Baristanet Profile: Michael Sherman
Iran war drives US fuel surcharges, but also industry profits
Iran war mediators focus on reopening Strait of Hormuz
Mojtaba Khamenei stays invisible six months into existential war
Survivors of Nepal Flood Left in Stunned Disbelief: ‘They All Died, and I Lived’
In Trump’s Washington, Ballooning National Debt Stirs Little Action